Allergic reactions to drugs and biologic agents

JAMA

Volumn 278, Issue 22, 1997, Pages 1895-1906

  DeShazo, Richard D ^a   Kemp, Stephen F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIMALARIAL AGENT; ASPARAGINASE; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; CHYMOPAPAIN; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GOLD DERIVATIVE; GRISEOFULVIN; HYDRALAZINE; INSULIN; LOCAL ANESTHETIC AGENT; METHYLDOPA; NEUROLEPTIC AGENT; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PENICILLIN DERIVATIVE; PHENOLPHTHALEIN; PROCAINAMIDE; QUINIDINE; STREPTOKINASE; SULFONAMIDE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ANAPHYLAXIS; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HISTAMINE RELEASE; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIZATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

EID: 0031457407     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.22.1895     Document Type: Review

References (90)

1. DeSwarte RD. Drug allergy. In: Patterson R, Grammer LC, Greenberger PA, Zeiss CR, eds. Allergic Diseases: Diagnosis and Management. 4th ed. Philadelphia, Pa: JB Lippincott; 1993:395-551.
2. Borda IT, Slone D, Jick H. Assessment of adverse reactions within a drug surveillance program. JAMA. 1968;205:645-647.
3. Faich GA. Adverse drug reaction monitoring. N Engl J Med. 1986;314:1589-1592.
4. Ives TJ, Bentz EJ, Gwyther RE. Drug-related admissions to a family medicine inpatient service. Arch Intern Med. 1987;147:1117-1120.
5. Boston Collaborative Drug Surveillance Program. Drug-induced anaphylaxis: a cooperative study. JAMA. 1973;224:613-615.
6. Armstrong B, Dinan B, Jick H. Fatal drug reactions in patients admitted to surgical services. Am J Surg. 1976;132:643-645.
7. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA. 1977;237:879-881.
8. Rawlins MD, Thompson W. Mechanisms of adverse drug reactions. In: Davies DM, ed. Textbook of Adverse Drug Reactions. New York, NY: Oxford University Press; 1991:18-45.
9. Chutka DS, Evans J, Fleming KC, Mikkelson KG. Drug prescribing for elderly patients. Mayo Clin Proc. 1995;70:685-693.
10. Parker CW, Kern M, Eisen HN. Polyfunctional dinitrophenol haptens as reagents for elicitation of immediate type allergic skin responses. J Exp Med. 1962;115:789-801.
11. Adkinson NF. Risk factors for drug allergy. J Allergy Clin Immunol. 1984;74:567-572.
12. Stark BJ, Earl HS, Gross GN, Lumry WR, Goodman EL, Sullivan TJ. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol. 1987;79:523-532.
13. Girard JP, Cattin S, Cuevas M. Immunological mechanisms and diagnostic tests in allergic drug reactions. Ann Clin Res. 1976;8:74-84.
14. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975-1982. JAMA. 1986;56: 3358-3363.
15. Lang DM, Alpern MB, Visintainer PF, Smith ST. Gender risk for anaphylactoid reaction to radiographic contrast media. J Allergy Clin Immunol. 1995;95:813-817.
16. Attaway NJ, Jasin HM, Sullivan TJ. Familial drug allergy. J Allergy Clin Immunol. 1991;87:227. Abstract.
17. Sullivan TJ, Ong RC, Gilliam LK. Studies of the multiple drug allergy syndrome. J Allergy Clin Immunol. 1989;83:270. Abstract.
18. Kamada MM, Twarog F, Leung DYM. Multiple antibiotic sensitivity in a pediatric population. Allergy Proc. 1991;12:347-350.
19. Becker LC. Allergy in systemic lupus erythematosus. Johns Hopkins Med J. 1973;133:38-44.
20. Wood AJJ. Adverse reactions to drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw Hill Book Co Inc; 1994:407-411.
21. Landor M, Lashinsky A, Waxman J. Quinolone allergy? Ann Allergy Asthma Immunol. 1996;77: 273-276.
22. Rasmussen JE. Erythema multiforme: should anyone care about the standards of care? Arch Dermatol. 1995;131:726-729.
23. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-1285.
24. Patterson R, Miller M, Kaplan M, et al. Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis. Ann Allergy. 1994;73:27-34.
25. Cheriyan S, Patterson R, Greenberger PA, Grammer LC, Latall J. The outcome of Stevens-Johnson syndrome treated with corticosteroids. Allergy Proc. 1995;16:151-155.
26. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333: 1600-1607.
27. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155: 2285-2290.
28. Stanley J, Faccon-Pellicci V. Phenytoin hypersensitivity reaction. Arch Dermatol. 1978;14:1350-1353.
29. Mackowiak PA, LeMaistre CF. Drug fever: a critical appraisal of conventional concepts. Ann Intern Med. 1987;106:728-733.
30. Torres MJ, Garcia JJ, Del CaZo Moratinos AM, Rondón C, Blanca M. Fixed drug eruption induced by mepivacaine. J Allergy Clin Immunol. 1995;96: 130-131.
31. Maibach HI, Dannaker CJ, Lahti A. Contact skin allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. 4th ed. St. Louis, Mo: Mosby-Year Book; 1993:1605-1647.
32. Adams RM. Recent advances in contact dermatitis. Ann Allergy. 1991;67:552-566.
33. Dooms-Goossens AE, Degreef HF, Mariën KJC, Coopman SA. Contact allergy to corticosteroids: a frequently missed diagnosis? J Am Acad Dermatol. 1989;21:538-543.
34. Podevin P, Broar M. Drug-induced 'allergic hepatitis.' Clin Rev Allergy Immunol. 1995;13:223-244.
35. Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 1995;333:1118-1127.
36. Patterson R, DeSwarte RD, Greenberger PA, Grammer LC, Brown JE, Choy AC. Drug Allergy and Protocols for Management of Drug Allergies. 2nd ed. Providence, RI: OceanSide Publications; 1995:1-27.
37. Anderson JA. Allergic reactions to drugs and biologic agents. JAMA. 1992;268:2845-2857.
38. Gadde J, Spence M, Wheeler B, Adkinson NF. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993;270:2456-2463.
39. Lin RY. A perspective on penicillin allergy. Arch Intern Med. 1992;152:930-937.
40. Sullivan TJ, Wedner HJ, Schatz GS, Yecies LD, Parker CW. Skin testing to detect penicillin allergy. J Allergy Clin Immunol. 1981;68:171-180.
41. Sogn DD, Evans R III, Shepherd GM, et al. Results of NIAID collaborative clinical trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med. 1992;152:1025-1032.
42. Sullivan TJ. Drug allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW eds. Allergy: Principles and Practice. 4th ed. St. Louis, Mo: Mosby-Year Book; 1993:1726-1746.
43. deShazo RD. Allergic reactions to drugs. In: Rakel RE, ed. Conn's Current Therapy. Philadelphia, Pa: WB Saunders Co; 1997;1:766-775.
44. Naclerio R, Mizrahi EA, Adkinson NF. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol. 1987;79:523-532.
45. Blanca M, Vega JM, Garcia J, et al. New aspects of allergic reactions to betalactams: cross-reactions and unique specificities. Clin Exp Allergy. 1994;24: 407-415.
46. Atkinson TP, Kaliner MA. Anaphylaxis. Med Clin North Am. 1992;76:841-855.
47. Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld SI. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol. 1991;88:213-217.
48. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987;107:204-215.
49. Meekins CV, Sullivan TJ, Gruchalla RS. Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins. J Allergy Clin Immunol. 1994; 94:1017-1024.
50. Beall G, Sanno M, Hussain H. Drug reactions and desensitization in AIDS. Immunol Allergy Clin North Am. 1997;17:319-337.
51. Moreno JN, Poblete RB, Maggio C, Gagnon S, Fischl MA. Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. Ann Allergy Asthma Immunol. 1995;74:140-146.
52. Meyers S, Sachar DB, Present DH, Janowitz HD. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology. 1987;93:1255-1262.
53. Purdy BH, Phillips DM, Summers RW. Desensitization for sulfasalazine skin rash. Ann Intern Med. 1984;100:512-514.
54. Stevenson DD. Aspirin and nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am. 1995;15:529-552.
55. Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995;96:480-485.
56. Bush RK, Zoratti E, Taylor SL. Diagnosis of sulfite and aspirin sensitivity. Clin Rev Allergy. 1990;8:159-178.
57. Christie PE, Smith CM, Lee TH. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis. 1991;144:957-958.
58. Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993;148:1447-1451.
59. Bigby M, Stern R. Cutaneous reaction to nonsteroidal anti-inflammatory drugs: a review. J Am Acad Dermatol. 1985;12:866-876.
60. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol. 1991;88:830-837.
61. Strom BL, Carson JL, Morse ML, West SL, Soper KA. The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1987;30:1142-1148.
62. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis: a review of 266 cases. Arch Intern Med. 1995;155:1749-1754.
63. Bush WH, Swanson DP. Radiocontrast. Immunol Allergy Clin North Am. 1995;15:597-612.
64. Lieberman P. Anaphylactoid reactions to radio-contrast material. Ann Allergy. 1991;67:91-100.
65. Enright T, Chua-Lim A, Duda E, Lim DT. The role of a documented allergic profile as a risk factor for radiographic contrast media reaction. Ann Allergy. 1989;62:302-305.
66. Dawson P, Edgerton D. Contrast media and enzyme inhibition, I: cholinesterase. Br J Radiol. 1983; 56:653-656.
67. Lalli AF. Contrast media reactions: data analysis and hypothesis. Radiology. 1980;134:1-12.
68. Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. 1991;87:867-872.
69. deShazo RD, Boehm TM, Kumar D, Galloway TA, Druak HF. Dermal reactions to insulin: correlations of three patterns to their histopathology. J Allergy Clin Immunol. 1982;69:229-237.
70. Galloway J, deShazo RD. Insulin chemistry and pharmacology: insulin allergy, resistance and lipodystrophy. In: Rifkin H, Porte D Jr, eds. Diabetes Mellitus Theory and Practice. 4th ed. New York, NY: Elsevier; 1990:497-513.
71. Dykewicz MS, McGrath KG, Davison R, Kaplan KJ, Patterson R. Identification of patients at risk for anaphylaxis due to streptokinase. Arch Intern Med. 1986;146:305-307.
72. Weiler JM, Gellhaus MA, Carter JG, Meng RL, Benson PM, Hottel RA. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. J Allergy Clin Immunol. 1990;85:713-719.
73. Wilson T, Höjer B, Tomson G. High incidence of a concentration dependent skin reaction in children treated with phenytoin. BMJ. 1978;1:1583-1586.
74. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med. 1992;117: 234-242.
75. Hedner T, Samuelsson O, Lunde H, Lindholm L, Andrén L, Wiholm BE. Angioedema in relation to treatment with angiotensin converting enzyme inhibitors. BMJ. 1992;304:941-946.
76. Tunon-de-Lara JM, Villanueva P, Marcus M, Taytard A. ACE inhibitors and anaphylactoid reactions during venom immunotherapy. Lancet. 1992; 340:908. Abstract.
77. Schaefer RM, Schaeffer L, Hörl WH. Anaphylactoid reactions during hemodialysis. Clin Nephrol. 1994;44(suppl 1):S44-S47.
78. Acker CG, Greenberg A. Angioedema induced by the angiotensin II blocker losartan. N Engl J Med. 1995;333:1572. Abstract.
79. Smith DL, deShazo RD. Local anesthetics and neuromuscular blocking agents. Immunol Allergy Clin North Am. 1995;15:613-634.
80. Gall H, Kaufmann R, Kalveram CM. Adverse reactions to local anesthetics: analysis of 197 cases. J Allergy Clin Immunol. 1996;97:933-937.
81. deShazo RD, Nelson HS. An approach to the patient with a history of local anesthetic hypersensitivity: experience with 90 patients. Allergy Clin Immunol. 1979;63:387-394.
82. Peter G, ed. Report of the Committee on Infectious Diseases. 22nd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1991:29.
83. James JM, Burks W, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med. 1995;332: 1262-1266.
84. Kesarwala HH. Immunization and immunoprophylaxis. In: Lawlor GJ Jr, Fischer TJ, Adelman DC, eds. Manual of Allergy and Immunology. 3rd ed. Boston, Mass: Little Brown & Co; 1995:460-482.
85. Bielory LC, Gascon P, Lawley TJ, Young NS, Frank MM. Human serum sickness: a propective analysis of 35 patients treated with equine antithymocyte globulin for bone marrow failure. Medicine. 1988;67:40-57.
86. Smith DL, deShazo RD. Drug reactions. In: Lichtenstein LM, Fauci AS, eds. Current Therapy in Allergy, Immunology and Rheumatology. 5th ed. Philadelphia, Pa: Mosby-Year Book Inc; 1996:156-163.
87. Jacobs RL, Lowe RS, Lanie BQ. Adverse reactions to tetanus toxiod. JAMA. 1982;247:40-42.
88. Earl HS, Sullivan TJ. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol. 1987;79:477-483.
89. Zimmerman GC, Keeling JH, Burris HA, et al. Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent. Arch Dermatol. 1995;131:202-206.
90. Anderson MV, deShazo RD. Anaphylaxis and anaphylactoid reaction. In: Taylor RE, ed. Difficult Medical Management. Philadelphia, Pa: WB Saunders Co; 1991:25-31.